Skip to main content

Table 3 IL-10 polymorphisms and risk of PCa

From: Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese

Genotype/Allele/haplotype

Controls n (%)

PCa n (%)

P

Adjusted OR* (95%CI)

Genotype(-1082A/G)

    

   AA

240(88.9)

222(84.7)

 

1.00

   AG

27(10.0)

36(13.7)

0.141

1.50(0.87~2.57)

   GG

3(1.1)

4(1.5)

0.520

1.68(0.35~8.17)

Allele

    

   A

507(93.9)

480(91.6)

 

1.00

   G

33(6.1)

44(8.4)

0.113

1.48(0.91~2.38)

Genotype(-819 C/T)

    

   TT

132(48.9)

120(45.9)

 

1.00

   TC

110(40.7)

108(41.2)

0.675

1.08(0.75~1.56)

   CC

28(10.4)

34(12.9)

0.296

1.35(0.77~2.36)

Allele

    

   T

374(69.3)

348(66.4)

 

1.00

   C

166(30.7)

176(33.6)

0.309

1.14(0.88~1.48)

Genotype(-592 C/A)

    

   AA

132(48.8)

120(45.9)

 

1.00

   AC

110(40.8)

108(41.2)

0.675

1.08(0.75~1.56)

   CC

28(10.4)

34(12.9)

0.296

1.35(0.77~2.36)

Allele

    

   A

374(69.3)

348(66.4)

 

1.00

   C

166(30.7)

176(33.6)

0.309

1.14(0.88~1.48)

Haplotype

    

   ATA

368(68.1)

340(64.9)

 

1.00

   ACC

139(25.7)

140(26.7)

0.551

1.13(0.86~1.47)

   GTA

6(1.1)

8(1.5)

0.489

1.42(0.56~4.12)

   GCC

27(5.0)

36(6.9)

0.174

1.45(0.86~2.47)

  1. OR*, adjusted for age and smoking status